Baron Peter Piot

Handa Professor of Global Health

United Kingdom


Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health


Centre for Evaluation

Selected Publications

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
CHOI, EM-L; Lacarra, B; AFOLABI, MO; Ale, BM; Baiden, F; Bétard, C; Foster, J; Hamzé, B; Schwimmer, C; Manno, D; D'Ortenzio, E; Ishola, D; Keita, CM; Keshinro, B; Njie, Y; Van Dijck, W; Gaddah, A; Anumendem, D; Lowe, B; Vatrinet, R; Lawal, BJ; Otieno, GT; Samai, M; Deen, GF; Swaray, IB; ... EBOVAC-3/EBL2005 Study Team,
The Lancet Global health
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
PREVAC Study Team,; Kieh, M; Richert, L; Beavogui, AH; Grund, B; Leigh, B; D'Ortenzio, E; Doumbia, S; Lhomme, E; Sow, S; Vatrinet, R; Roy, C; Kennedy, SB; Faye, S; LEES, S; Millimouno, NP; Camara, AM; Samai, M; Deen, GF; Doumbia, M; Espérou, H; Pierson, J; WATSON-JONES, D; Diallo, A; Wentworth, D; ... Yazdanpanah, Y.
The New England journal of medicine
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
Barry, H; Mutua, G; Kibuuka, H; ANYWAINE, Z; Sirima, SB; Meda, N; Anzala, O; Eholie, S; Bétard, C; Richert, L; Lacabaratz, C; McElrath, MJ; De Rosa, S; Cohen, KW; Shukarev, G; Robinson, C; Gaddah, A; Heerwegh, D; Bockstal, V; Luhn, K; Leyssen, M; Douoguih, M; Thiébaut, R; EBL2002 Study group,;
PLoS medicine
Future scenarios for the COVID-19 pandemic.
Skegg, D; Gluckman, P; Boulton, G; Hackmann, H; Karim, SS A; PIOT, P; Woopen, C;
Lancet (London, England)
Towards Societies Living with COVID-19
China CDC Weekly
Defeating neglected tropical diseases in our new world living with COVID-19.
Martínez-Juárez, LA; Álvarez-Hernandez, D-A; Sedas, AC; SPENCER, J; PIOT, P;
Therapeutic Advances in Infectious Disease
Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
Celum, C; Barnabas, R; Cohen, MS; Collier, A; El-Sadr, W; Holmes, KK; Johnston, C; PIOT, P;
The New England journal of medicine
The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19.
Norton, A; De La Horra Gozalo, A; Feune de Colombi, N; Alobo, M; Mutheu Asego, J; Al-Rawni, Z; Antonio, E; Parker, J; Mwangi, W; Adhiambo Wesonga, C; Marsh, K; Tufet, M; PIOT, P; Lang, T;
BMJ global health
Strengthening the global effort on COVID-19 research.
Norton, A; Mphahlele, J; Yazdanpanah, Y; PIOT, P; Bayona, MT;
Lancet (London, England)
See more information